DPC2019 Exhibitor

Boehringer Ingelheim & Lilly Alliance

E5

The alliance leverages the companies’ strength as two of the world’s leading pharmaceutical companies, combining Boehringer Ingelheim’s solid track record of research-driven innovations and Lilly’s innovative research, experience, and pioneering history in diabetes. By joining forces, the companies demonstrate commitment in the care of patients with diabetes and stand together to focus on patient needs.

Boehringer Lilly Logo